The U.S. Military Is Funding MDMA-Assisted Therapy Research for PTSD (For Real)
A Department of Defense (DoD)-funded clinical trial will study MDMA-assisted therapy paired with Massed Prolonged Exposure for PTSD in active-duty service members. For decades, MDMA lived far outside the walls of official medicine. Let alone the U.S. military. That wall just moved. The U.S. Department of Defense is funding a $4.9 million clinical trial investigating…
You might be interested in
Even the Feds Say Teen Marijuana Use Is Declining
For years, critics of cannabis reform have leaned on the same warning: legal weed will lead to more teens using marijuana. The data keeps telling a different story. According to newly released, federally funded survey data compiled by researchers at the University of Michigan, teen marijuana use has continued its long-term decline and now sits…
You might be interested in
How the Cannabis Lobby Finally Got Trump to Budge
Cannabis didn’t win Trump over with a single argument. It wore him down. For more than a year, executives, advocates, pollsters and old friends circled one of the most famously sober presidents in modern history, pushing a narrow idea again and again: marijuana doesn’t belong in the same federal category as heroin. By the time…
You might be interested in
Trump Wants Marijuana Rescheduling Done Fast — Possibly by January
President Donald Trump has directed Attorney General Pam Bondi to move quickly on finalizing marijuana’s potential reclassification under federal law, following an executive order signed earlier this month. According to The Marijuana Herald, which cited two sources close to the president, Trump privately instructed Bondi to complete the rescheduling process by the end of January.…
You might be interested in
The Cannabis Justice Crisis Still Haunting 2025: Parker Coleman’s 60-Year Sentence Is a National Shame
In 2025, cannabis is everywhere and nowhere at the same time. Everywhere in the sense that you can buy it legally in glittery storefronts, order it for delivery like pizza, see it advertised on billboards, hear politicians brag about the tax revenue, and watch corporate executives talk about “innovation” with the same straight face Big…
You might be interested in
Adventures with Santa: Puff, Puff, Pass with Josh Kesselman
For more than a decade, “Adventures with Santa” has appeared in magazines around the world: a fictional series blending holiday magic with cannabis culture, compassion, and plant wisdom. Each year, Santa drops in on real figures from the cannabis community for a little medicine, a little conversation, and a reminder of why this plant matters.…
You might be interested in
Wall Street Wants Stock Listings. Cannabis Wants Justice.
The ink was barely dry on President Trump’s cannabis rescheduling order when the same question started bouncing around boardrooms, Discords, and trader timelines: Does this mean cannabis can finally uplist to the NYSE or Nasdaq? Short answer: no. Longer answer: also no, and maybe stop treating Wall Street like it’s the finish line. Schedule III…
You might be interested in
Operation Green Merchant: The Morning the Drug War Kissed Its Own Reflection
How a nationwide DEA dragnet in 1989 turned garden shops into crime scenes, and taught the War on Drugs to police an idea. The first light of dawn had barely bled over the strip mall when the shutters screeched open. A dozen black-clad agents spilled out of unmarked vans. They smashed glass, padlocked doors, and…
You might be interested in
People Are Getting Their AI High: Paying to ‘Alter’ Chatbot’s Consciousness
Artificial Intelligence (AI) has reached a level of everyday intimacy where it’s starting to feel like a friend. We argue over dinner recipes, plan trips, ask how to fix things around the house, and sometimes even bring our personal dilemmas to it (an intimacy that, as we’re learning, doesn’t always come without risks). This is…
You might be interested in
Cannabis Rescheduling: What the Executive Order Doesn’t Do — and Who It Actually Helps
Editor’s Note: High Times has long supported the removal of cannabis from Schedule I and ultimately federal descheduling. The following guest column reflects the legal analysis of the author and examines what current rescheduling efforts do (and do not) mean for today’s cannabis operators. By Jason W. Klimek, partner and cannabis industry team co-leader at…
You might be interested in